(Q40167073)

18 September 2017

1 reference

title

Cellular pharmacokinetics of the phenylalanine mustards (English)

1 reference

18 September 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

7 October 2023

author name string

D. T. Vistica

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6361804

7 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6361804

7 October 2023

publication date

1 January 1983

1 reference

full work available at URL

18 September 2017

https://api.elsevier.com/content/article/PII:0163725883900098?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

https://api.elsevier.com/content/article/PII:0163725883900098?httpAccept=text/plain

7 October 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Pharmacology & Therapeutics

7 October 2023

published in

1 reference

18 September 2017

volume

22

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

379-406

1 reference

Hypoxic cell sensitizers for radiotherapy

18 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

7 October 2023

Oral melphalan kinetics

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Kinetics of intravenous melphalan

7 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Comparison of nitrogen-mustard-sensitive and -resistant yoshida sarcomas

7 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

A comparison of melphalan transport in human breast cancer cells and lymphocytes in vitro

7 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Mechanism of efflux of melphalan from L5178Y lymphoblasts in vitro

7 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Membrane transport, sulfhydryl levels and DNA cross-linking in Chinese hamster ovary cell mutants sensitive and resistant to melphalan.

7 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines

7 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma

7 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line

7 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

TUMOUR SULPHYDRYL LEVELS AND SENSITIVITY TO THE NITROGEN MUSTARD MEROPHAN

7 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)

7 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole

7 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

The effect of nitrogen mustards on the incorporation of amino acids into protein by Staphylococcus aureus

7 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

7 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary

7 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

L-phenylalanine mustard (L-PAM): the first 25 years

7 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides

7 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Evidence for carrier-mediated transport of melphalan by L5178Y lymphoblasts in vitro

7 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Membrane transport of alkylating agents

7 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)

7 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Primary Bioassay of Human Tumor Stem Cells

7 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Studies on plant amylases: The effect of starch concentration upon the velocity of hydrolysis by the amylase of germinated barley

7 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

A comparison of methods for estimating the viable count of a suspension of tumour cells

7 October 2023

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

STUDIES ON THE ANTI-TUMOUR ACTIVITY OF p-DI-(2-CHLOROETHYL) AMINOPHENYLALANINE (SARCOLYSINE)

7 October 2023

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Effects of Some Chemical Mutagens and Carcinogens on Nucleic Acids

7 October 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukaemia cells in vitro

7 October 2023

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Tumor cytotoxicity. Quantitative changes in DNA synthesis as an indicator

7 October 2023

55

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Melphalan-induced chromosome damage in sensitive and resistant human melanoma cell lines

7 October 2023

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Mechanism of melphalan resistance developed in vitro in human melanoma cells

7 October 2023

62

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Counting actively metabolizing tissue cultured cells

7 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Studies on the mechanism of resistance to alkylating agents of three ascites tumours in the rat.

7 October 2023

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Transport of melphalan by sensitive and resistant L1210 cells

7 October 2023

66

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Comparison of in vitro methods to determine drug-induced cell lethality

7 October 2023

68

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Cell survival following treatment with antitumor drugs

7 October 2023

69

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links

7 October 2023

72

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Comparative antitumor effects of peptichemio and other alkylating agents

7 October 2023

73

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustard

7 October 2023

74

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Potentiation of antitumor drug action by centrophenoxine: specificity

7 October 2023

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Cytotoxic activity of alkylating agents in the presence of centrophenoxine and its hydrolysis products

7 October 2023

79

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

7 October 2023

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content.

7 October 2023

82

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease

7 October 2023

84

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells

7 October 2023

88

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells

7 October 2023

89

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Cytotoxicity as an indicator for transport mechanism. Evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell

7 October 2023

91

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Concentrative uptake of melphalan, a cancer chemotherapeutic agent which is transported by the leucine-preferring carrier system

7 October 2023

92

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Substrate specificity of a high-affinity, monovalent cation-dependent amino acid carrier

7 October 2023

93

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transport

7 October 2023

94

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Effect of L-α-amino-γ-guanidinobutyric acid on melphalan therapy of the L1210 murine leukemia

7 October 2023

95

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Cytotoxicities of the L and D isomers of phenylalanine mustard in L 1210 cells

7 October 2023

96

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells

7 October 2023

97

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Carrier mechanism and specificity accounting for the increase in intracellular melphalan by the basic amino acids

7 October 2023

99

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Uptake of melphalan by human ovarian carcinoma cells and its relationship to the amino acid content of ascitic fluid

7 October 2023

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier

7 October 2023

104

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamide

7 October 2023

107

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90009-8

7 October 2023

Identifiers

1 reference

18 September 2017

1 reference